Evolus (EOLS) Net Cash Flow (2017 - 2026)
Evolus' (EOLS) quarterly Net Cash Flow came in at -$4.0 million in Q1 2026, up 78.96% YoY from -$2.2 million in Q1 2025, and down 137.47% on a QoQ basis from $10.7 million in Q4 2025.
Evolus (EOLS) Net Cash Flow (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Net Cash Flow data on file, last reported at -$4.0 million in Q1 2026.
- Quarterly Net Cash Flow rose 78.96% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.3 million (up 36.49% YoY) and the FY2025 annual result came in at -$33.4 million, down 235.74% from the prior year.
- Net Cash Flow fell to -$4.0 million in Q1 2026, from $10.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $34.2 million in Q1 2024 to a low of -$39.5 million in Q1 2022.
- A 5-year average of -$5.6 million and a median of -$6.4 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow slumped 196.6% — and 2025, when it surged 403.42%.
- Tracing EOLS's Net Cash Flow over 5 years: stood at -$11.7 million in 2022, then surged by 305.24% to $24.0 million in 2023, then plunged by 91.1% to $2.1 million in 2024, then surged by 403.42% to $10.7 million in 2025, then slumped by 137.47% to -$4.0 million in 2026.
- The last three Net Cash Flow figures came in at -$4.0 million (Q1 2026), $10.7 million (Q4 2025), and -$18.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evolus | 550.84 Mn | 505.67 Mn | 57.18 Mn | -4.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.45 Mn |
| Jun 30, 2026 | -4.45 Mn |
| Mar 31, 2026 | -4.02 Mn |
| Mar 31, 2026 | -4.02 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Sep 30, 2025 | -18.60 Mn |
| Sep 30, 2025 | -18.60 Mn |
| Jun 30, 2025 | -6.40 Mn |
| Jun 30, 2025 | -6.40 Mn |
| Mar 31, 2025 | -19.12 Mn |
| Mar 31, 2025 | -19.12 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | -8.55 Mn |
| Sep 30, 2024 | -8.55 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Jun 30, 2024 | -3.24 Mn |
| Mar 31, 2024 | 34.25 Mn |
| Mar 31, 2024 | 34.25 Mn |